Kadcyla 160mg Injection

Roche Products India Pvt Ltd

NOT FOR SALE

Composition FOR Kadcyla 160mg Injection

Ado-trastuzumab emtansine(160mg)

food interaction for Kadcyla Injection

alcohol interaction for Kadcyla Injection

pregnancy interaction for Kadcyla Injection

lactation interaction for Kadcyla Injection

food

alcohol

pregnancy

lactation

No interaction found/established

It is not known whether it is safe to consume alcohol with Kadcyla 160mg Injection. Please consult your doctor.

CONSULT YOUR DOCTOR

Kadcyla 160mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

CONSULT YOUR DOCTOR

Kadcyla 160mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

UNSAFE

SALT INFORMATION FOR Kadcyla 160mg Injection

Ado-trastuzumab emtansine(160mg)

Kadcyla injection uses

{med_name} is used in the treatment of breast cancer and metastatic breast cancer. It is used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines.

How kadcyla injection works

Kadcyla 160mg Injection is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body's immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.

Common side effects of kadcyla injection

Tiredness, Nausea, Musculoskeletal (bone, muscle or joint) pain, Bleeding, Low blood platelets, Headache, Liver disorder, Constipation, Nosebleeds

SUBSTITUTES FOR Kadcyla Injection

No substitutes found

Expert advice FOR Kadcyla Injection

Ado-trastuzumab emtansine is given via a drip into a vein (intravenous infusion) under the supervision of a doctor.
Do not skip any dose and complete the course as suggested by your doctor.
Your doctor may check your liver function before starting treatment and regularly thereafter. Inform your doctor if you notice yellowing of eyes or skin, dark urine, or stomach pain.
Women who could get pregnant should use a reliable method of contraception to prevent pregnancy while taking this medicine.
Regular monitoring of heart function (tests like echocardiogram) and blood tests to monitor the level of blood cells may be advised before starting treatment and regularly during treatment with Ado-trastuzumab emtansine.

Frequently asked questions FOR Kadcyla 160mg Injection

Ado-trastuzumab emtansine

Q. What is the use of Kadcyla 160mg Injection?

Kadcyla 160mg Injection is used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab and a taxane.

Q. How is Kadcyla 160mg Injection different?

Kadcyla 160mg Injection is a conjugate of the HER2 directed trastuzumab and a highly toxic microtubule-targeted drug (emtansine). Thus it is made up of 2 cancer-fighting agents in 1 medicine- The monoclonal antibody trastuzumab and a chemotherapy emtansine. Kadcyla 160mg Injection brings chemotherapy medicine (emtansine) into HER2-positive cells and kills them. It is designed to cause less harm to normal cells.